ILCA 2025 Single Topic Workshop on Y90 and TACE in HCC and BTCs in Chicago
June 6
The ILCA 2025 Single Topic Workshop on Y90 and TACE in HCC and BTCs will be held on June 6, 2025 in Chicago, IL. This workshop focuses on the evolving role of Y90 (Yttrium-90) and TACE (Transarterial Chemoembolization) in treating Hepatocellular Carcinoma (HCC) and Biliary Tract Cancers (BTCs).
Key Highlights:
- Basic principles of embolization and immunotherapy in managing HCC and BTC.
- Future perspectives on neoadjuvant and adjuvant treatments.
- Current state of science for Y90 and TACE in HCC and BTC.
- Hepatic artery infusion treatments.
- Dynamic treatment landscape as patients migrate between treatments.
- Combination treatments of locoregional and systemic therapies.
- Ongoing clinical trials combining systemic and locoregional therapies.
The workshop aims to foster intimate conversations and real collaboration among experts in the field.
Don’t miss this opportunity to engage with leading experts, explore cutting-edge research, and collaborate on innovative treatment strategies.
Register now to secure your spot and be part of the future of cancer treatment!
Date: June 6, 2025
Location: Chicago, IL
Click Here To Learn More
English 
French